Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorota Lubgan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Postepy Biochemii|July 28, 2006
[Transferrin conjugates in the anticancer therapy]Dorota Lubgan, Agnieszka Marczak, Luitpold Distel, et al.
JCO Clinical Cancer Informatics|October 11, 2019
Noncurated Data Lead to Misinterpretation of Treatment Outcomes in Patients With Prostate Cancer After Salvage or Palliative RadiotherapySandra Rutzner, Thomas Ganslandt, Rainer Fietkau, et al.
Frontiers in Oncology|February 25, 2017
Electronic Support for Retrospective Analysis in the Field of Radiation Oncology: Proof of Principle Using an Example of Fractionated Stereotactic Radiotherapy of 251 Meningioma PatientsSandra Rutzner, Rainer Fietkau, Thomas Ganslandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 13, 2021
12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?Dorota Lubgan, Sabine Semrau, Ulrike Lambrecht, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 15, 2014
Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary resultsDorota Lubgan, Anke Ziegaus, Sabine Semrau, et al.
International Journal of Molecular Sciences|November 26, 2022
Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer CellsAnastazja Poczta, Piotr Krzeczyński, Maksim Ionov, et al.
Journal of Neuro-Oncology|July 2, 2017
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningiomaDorota Lubgan, Sandra Rutzner, Ulrike Lambrecht, et al.
Clinical and Translational Radiation Oncology|June 26, 2025
Comparison of dose calculation approaches and clinical dose-response in image-guided head&neck brachytherapy of the oral cavitySabrina Schaller, Vratislav Strnad, Claudia Schweizer, et al.
Brachytherapy|June 1, 2022
Permanent LDR prostate brachytherapy: Comprehensive characterization of seed-dynamics within the prostate on a seed-only levelAndre Karius, Michael Lotter, Stephan Kreppner, et al.
BMC Medical Informatics and Decision Making|December 11, 2013
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine dataFelix Köpcke, Dorota Lubgan, Rainer Fietkau, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Postepy Biochemii|July 28, 2006
[Transferrin conjugates in the anticancer therapy]Dorota Lubgan, Agnieszka Marczak, Luitpold Distel, et al.
JCO Clinical Cancer Informatics|October 11, 2019
Noncurated Data Lead to Misinterpretation of Treatment Outcomes in Patients With Prostate Cancer After Salvage or Palliative RadiotherapySandra Rutzner, Thomas Ganslandt, Rainer Fietkau, et al.
Frontiers in Oncology|February 25, 2017
Electronic Support for Retrospective Analysis in the Field of Radiation Oncology: Proof of Principle Using an Example of Fractionated Stereotactic Radiotherapy of 251 Meningioma PatientsSandra Rutzner, Rainer Fietkau, Thomas Ganslandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 13, 2021
12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?Dorota Lubgan, Sabine Semrau, Ulrike Lambrecht, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 15, 2014
Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary resultsDorota Lubgan, Anke Ziegaus, Sabine Semrau, et al.
International Journal of Molecular Sciences|November 26, 2022
Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer CellsAnastazja Poczta, Piotr Krzeczyński, Maksim Ionov, et al.
Journal of Neuro-Oncology|July 2, 2017
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningiomaDorota Lubgan, Sandra Rutzner, Ulrike Lambrecht, et al.
Clinical and Translational Radiation Oncology|June 26, 2025
Comparison of dose calculation approaches and clinical dose-response in image-guided head&neck brachytherapy of the oral cavitySabrina Schaller, Vratislav Strnad, Claudia Schweizer, et al.
Brachytherapy|June 1, 2022
Permanent LDR prostate brachytherapy: Comprehensive characterization of seed-dynamics within the prostate on a seed-only levelAndre Karius, Michael Lotter, Stephan Kreppner, et al.
BMC Medical Informatics and Decision Making|December 11, 2013
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine dataFelix Köpcke, Dorota Lubgan, Rainer Fietkau, et al.
Pageof 2